Imazol

Clotrimazole, the active ingredient in Imazol, is an imidazole antifungal presented as a topical cream for skin use. It treats fungal skin infections such as athlete's foot, ringworm and yeast infections in adults and children. GNH USA supplies Imazol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imazol is a topical antifungal that acts on dermatophytes and yeasts causing skin disease. - Dermatophyte infections (tinea corporis, tinea cruris, tinea pedis): reduces fungal growth and relieves itching, redness and scaling. - Cutaneous candidiasis: eliminates skin yeast overgrowth and clears lesions. - Seborrheic dermatitis: controls Malassezia proliferation, decreasing flaking and irritation.

Topical clotrimazole is generally well tolerated, but local reactions can occur.

Common Side Effects: - Mild skin irritation or burning at the application site. - Itching or pruritus. - Redness or erythema. - Dryness or peeling of the skin. - Stinging sensation. - Minor swelling.

Serious or Rare Side Effects: - Allergic contact dermatitis with rash and blistering. - Severe skin reaction such as Stevens‑Johnson syndrome. - Extensive swelling or edema. - Systemic absorption leading to liver enzyme abnormalities (very rare). - Persistent ulceration or infection at the site. - Unexplained fever or malaise.

Before using Imazol, consider the following safety measures. - Pregnancy: consult a healthcare professional; safety data are limited. - Breastfeeding: avoid application to nipples and discuss with a doctor. - Age: not recommended for children under 2 years unless directed by a clinician. - Skin condition: do not apply to broken, inflamed or ulcerated skin. - Concurrent antifungal therapy: inform the prescriber of any other antifungal products. - Store at room temperature: keep in the original container, protect from moisture and heat.

Clotrimazole may interact with other medications when used concurrently.

Major Interactions (Avoid): - Systemic azole antifungals (e.g., fluconazole, itraconazole): may increase systemic exposure. - Strong CYP450 inhibitors (e.g., ketoconazole, erythromycin): potential for elevated clotrimazole levels.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may reduce antifungal efficacy. - Antifungal shampoos or soaps: concurrent use may increase skin irritation. - Alcohol‑based skin products: can enhance local irritation. - Other topical agents (e.g., retinoids): monitor for additive skin sensitivity.